表紙
市場調查報告書

細胞離析/細胞分離的全球市場 - 至2024年的預測:試劑,珠,離心機

Cell Isolation/Cell Separation Market by Product(Reagents, Beads, Centrifuge), Cell Type (Human, Animal), Cell Source (Bone Marrow, Adipose), Technique (Filtration), Application (Cancer), End User (Hospitals, Biotechnology) - Global Forecast to 2024

出版商 MarketsandMarkets 商品編碼 315175
出版日期 內容資訊 英文 196 Pages
訂單完成後即時交付
價格
細胞離析/細胞分離的全球市場 - 至2024年的預測:試劑,珠,離心機 Cell Isolation/Cell Separation Market by Product(Reagents, Beads, Centrifuge), Cell Type (Human, Animal), Cell Source (Bone Marrow, Adipose), Technique (Filtration), Application (Cancer), End User (Hospitals, Biotechnology) - Global Forecast to 2024
出版日期: 2019年02月20日內容資訊: 英文 196 Pages
簡介

細胞離析市場,預計將從2019年的59億美元,擴大到2024年130億美元的規模。市場在2019年∼2024年間預測將以年複合成長率 (CAGR) 17.2%的速度成長。

本報告提供全球細胞離析市場相關調查分析,市場概要,產業趨勢,各市場區隔的市場分析,競爭情形,主要企業等相關的系統性資訊。

第1章 簡介

第2章 調查手法

第3章 摘要整理

第4章 重要考察

  • 細胞離析:市場概要
  • 北美 - 細胞離析市場:各產品
  • 細胞離析市場各地區概述

第5章 市場概要

  • 簡介
  • 市場動態
    • 促進因素
    • 阻礙因素
    • 機會
    • 課題

第6章 細胞離析的全球市場:各產品

  • 簡介
  • 消耗品
  • 設備

第7章 細胞離析的全球市場:各細胞類型

  • 簡介
  • 人細胞
  • 動物細胞

第8章 細胞離析的全球市場:各細胞來源

  • 簡介
  • 骨髓
  • 脂肪組織
  • 臍帶血/ES (胚胎幹) 細胞

第9章 細胞離析的全球市場:各技術

  • 簡介
  • 離心分離
  • 表面標誌物
  • 過濾

第10章 細胞離析的全球市場:各用途

  • 簡介
  • 純粹分子分離
  • 癌症研究
  • 幹細胞研究
  • 組織再生、再生醫療
  • 體外診斷 (IVD)

第11章 細胞離析的全球市場:各終端用戶

  • 簡介
  • 生物科技、生物醫藥品企業
  • 研究所,研究機關
  • 醫院,臨床檢驗室
  • 其他

第12章 細胞離析的全球市場:各地區

  • 簡介
  • 北美
  • 歐洲
  • 亞太地區
  • 其他

第13章 競爭情形

  • 概要
  • 市場排行榜分析
  • 主要策略
  • 競爭領導製圖

第14章 企業簡介

  • THERMO FISHER SCIENTIFIC, INC.
  • BECTON, DICKINSON AND COMPANY
  • BECKMAN COULTER INC. (DANAHER CORPORATION的子公司)
  • MERCK KGAA
  • TERUMO BCT (Terumo Corporation的子公司)
  • GE HEALTHCARE
  • BIO-RAD LABORATORIES, INC.
  • MILTENYI BIOTEC
  • PLURISELECT LIFE SCIENCE UG (HAFTUNGSBESCHRANKT) & CO. KG
  • STEMCELL TECHNOLOGIES, INC.

第15章 附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: BT 2757

"The global cell isolation market is projected to register a CAGR of 17.2% during the forecast period."

The market size for cell isolation is expected to reach USD 13.0 billion by 2024 from USD 5.9 billion in 2019, at a CAGR of 17.2%. The growth in this market is attributed to the increasing number of patients suffering from cancer and infectious diseases, increasing government funding for cell-based research, technological advancements, and the growing focus on personalized medicine.

"The bone marrow segment is estimated to grow rapidly during the forecast period."

By cell source, the cell isolation market is segmented into three segments, namely, adipose tissue, bone marrow, and cord blood/embryonic stem cells. The bone marrow segment is projected to grow at the highest rate during the forecast period. This growth is attributed to the commercialization of a number of bone marrow-derived stem cell-based products for various therapeutic applications including aGVHD treatment, cardiovascular disease treatment, wound healing, tissue regeneration, and musculoskeletal disorders.

"The biomolecule isolation segment is estimated to grow rapidly during the forecast period."

Based on application, the cell isolation market is segmented into biomolecule isolation, cancer research, stem cell research, tissue regeneration & regenerative medicine, and in vitro diagnostics. During the forecast period, the biomolecule isolation segment is estimated to register the highest growth rate in the overall cell isolation market. This growth is mainly attributed to the increasing investments by companies for the production of biopharmaceutical products.

"Asia Pacific is estimated to register the highest CAGR during the forecast period."

In this report, the cell isolation market is segmented into four major regional segments-North America, Europe, Asia Pacific, and the Rest of the World (RoW). The market in Asia Pacific is projected to register the highest growth rate during the forecast period. The growth in this market is primarily driven by the increasing incidence of chronic and infectious diseases and a growing population.

Breakdown of Profiles of Primary Participants:

  • By Company Type: Tier 1-20%, Tier 2-45%, Tier 3-35%
  • By Designation: C-level-30%, Director Level - 20%, Others - 50%
  • By Region: North America-35%, Europe-24%, Asia-25%, Rest of the World - 16%

Key players in the cell isolation market include: Beckman Coulter (US), Becton, Dickinson and Company (US), GE Healthcare (US), Merck KgaA (Germany), Miltenyi Biotec (Germany), pluriSelect (Germany), STEMCELL Technologies Inc. (Canada), Terumo BCT (US), Thermo Fisher Scientific (US), and Bio-Rad Laboratories Inc. (US).

Research Coverage:

The report analyzes the cell isolation market by product, cell type, cell source, technique, application, end user, and region. Apart from a comprehensive geographic product analysis and market sizing, the report also provides a competitive landscape that covers the growth strategies adopted by market players over the last three years. In addition, the company profiles include the product portfolios, developments, and strategies adopted by prominent market players to maintain and increase their shares in the market. Market research data, current market size, and forecast of the future trends will help key market players and new entrants to make the necessary decisions regarding product offerings, geographic focus, change in strategic approach, and levels of output to remain successful in the market.

Key Benefits of Buying the Report:

This report will enable both established firms and new entrants/smaller firms to gauge the pulse of the market, which, in turn, will help these firms garner greater market shares. Firms purchasing the report can use any one or a combination of the below mentioned five strategies for strengthening their market shares.

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on the product portfolios of the top players in the cell isolation market
  • Product Development/Innovation: Detailed insights on the product approvals, R&D activities, and product launches in the cell isolation market
  • Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments, and product portfolios of the leading players in the cell isolation market
  • Market Development: Detailed information about emerging markets. The report analyzes the market for various cell isolation across geographies
  • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the cell isolation market

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
    • 1.2.1. MARKETS COVERED
    • 1.2.2. COUNTRY COVERAGE
    • 1.2.3. YEARS CONSIDERED FOR THE STUDY
  • 1.3. CURRENCY
  • 1.4. LIMITATIONS
  • 1.5. STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. SECONDARY DATA
    • 2.1.1. KEY DATA FROM SECONDARY SOURCES
  • 2.2. PRIMARY DATA
    • 2.2.1. KEY DATA FROM PRIMARY SOURCES
  • 2.3. MARKET SIZE ESTIMATION
    • 2.3.1. BOTTOM-UP APPROACH
    • 2.3.2. TOP-DOWN APPROACH
  • 2.4. MARKET BREAKDOWN AND DATA TRIANGULATION
  • 2.5. ASSUMPTIONS FOR THE STUDY

3. EXECUTIVE SUMMARY

4. PREMIUM INSIGHTS

  • 4.1. CELL ISOLATION: MARKET OVERVIEW
  • 4.2. NORTH AMERICA: CELL ISOLATION MARKET, BY PRODUCT (2018)
  • 4.3. GEOGRAPHICAL SNAPSHOT OF THE CELL ISOLATION MARKET

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
  • 5.2. MARKET DYNAMICS
    • 5.2.1. DRIVERS
      • 5.2.1.1. Increasing government funding for cell-based research
      • 5.2.1.2. Increasing number of patients suffering from cancer and infectious diseases
      • 5.2.1.3. Technological advancements
      • 5.2.1.4. Growing focus on personalized medicine
    • 5.2.2. RESTRAINTS
      • 5.2.2.1. Ethical issues related to embryonic stem cell isolation
      • 5.2.2.2. High cost of cell-based research
    • 5.2.3. OPPORTUNITIES
      • 5.2.3.1. Emerging markets

6. CELL ISOLATION MARKET, BY PRODUCT

  • 6.1. INTRODUCTION
  • 6.2. CONSUMABLES
    • 6.2.1. REAGENTS, KITS, MEDIA, AND SERA
      • 6.2.1.1. Owing to the disposable nature of reagents and assay kits, this market is driven by their consistent usage and frequent purchases
    • 6.2.2. BEADS
      • 6.2.2.1. Growing demand for magnetic beads in T-cell and stem cell isolation is a major factor driving growth in this product segment
    • 6.2.3. DISPOSABLES
      • 6.2.3.1. Increasing investments in research by governments and companies are a major factor boosting the growth of the cell isolation disposables market
  • 6.3. INSTRUMENTS
    • 6.3.1. CENTRIFUGES
      • 6.3.1.1. Growing use of centrifuges in the pharma-biotech industry and multi-functionality options offered by these instruments are driving the growth of this product segment
    • 6.3.2. FLOW CYTOMETERS
      • 6.3.2.1. Launch of innovative and cost-effective flow cytometers is likely to drive the growth of the market
    • 6.3.3. MAGNETIC-ACTIVATED CELL SEPARATOR SYSTEMS
    • 6.3.4. FILTRATION SYSTEMS
      • 6.3.4.1. Increasing research activities in cell biology to boost the market

7. CELL ISOLATION MARKET, BY CELL TYPE

  • 7.1. INTRODUCTION
  • 7.2. HUMAN CELLS
    • 7.2.1. DIFFERENTIATED CELLS
      • 7.2.1.1. Growing investments by market players to develop new and innovative products is expected to support the growth of the differentiated cell isolation market
    • 7.2.2. STEM CELLS
      • 7.2.2.1. Rising government initiatives focused on supporting stem cell research expected to drive market growth
  • 7.3. ANIMAL CELLS
    • 7.3.1. BIOPHARMACEUTICAL COMPANIES ARE THE MAJOR END USERS OF ISOLATED ANIMAL CELLS

8. CELL ISOLATION MARKET, BY CELL SOURCE

  • 8.1. INTRODUCTION
  • 8.2. BONE MARROW
    • 8.2.1. A NUMBER OF BONE MARROW-DERIVED STEM CELLS HAVE BEEN COMMERCIALIZED IN THE LAST DECADE
  • 8.3. ADIPOSE TISSUE
    • 8.3.1. ADIPOSE STEM/STROMAL CELLS CAN GENERATE A VARIETY OF OTHER CELL TYPES
  • 8.4. CORD BLOOD/EMBRYONIC STEM CELLS
    • 8.4.1. MARKET GROWTH IS DRIVEN BY THE HIGH THERAPEUTIC POTENCY OF THESE STEM CELLS

9. CELL ISOLATION MARKET, BY TECHNIQUE

  • 9.1. INTRODUCTION
  • 9.2. CENTRIFUGATION-BASED CELL ISOLATION
    • 9.2.1. COST-EFFECTIVENESS OF THIS TECHNIQUE IN BOTH SMALL-SCALE AND LARGE-SCALE OPERATIONS-A MAJOR DRIVER
  • 9.3. SURFACE MARKER-BASED CELL ISOLATION
    • 9.3.1. WIDE USAGE OF THIS TECHNIQUE IN BIOPHARMACEUTICAL AND BIOTECH INDUSTRIES IS A MAJOR REASON FOR THE GROWTH OF THIS MARKET
  • 9.4. FILTRATION-BASED CELL ISOLATION
    • 9.4.1. THE MAJOR FACTOR DRIVING THE GROWTH OF THIS MARKET SEGMENT IS THE LOW COST OF THE FILTRATION TECHNIQUE

10. CELL ISOLATION MARKET, BY APPLICATION

  • 10.1. INTRODUCTION
  • 10.2. BIOMOLECULE ISOLATION
    • 10.2.1. BIOMOLECULE ISOLATION DOMINATES THE CELL ISOLATION APPLICATIONS MARKET
  • 10.3. CANCER RESEARCH
    • 10.3.1. HIGH DISEASE INCIDENCE HAS FUELLED THE DEMAND FOR ADVANCED TREATMENT
  • 10.4. STEM CELL RESEARCH
    • 10.4.1. INCREASING FUNDING IN STEM CELL RESEARCH TO SUPPORT MARKET GROWTH
  • 10.5. TISSUE REGENERATION & REGENERATIVE MEDICINE
    • 10.5.1. FUNDING FOR REGENERATIVE MEDICINE INITIATIVES HAS RISEN
  • 10.6. IN VITRO DIAGNOSTICS
    • 10.6.1. RISING DISEASE INCIDENCE HAS DRIVEN DEMAND FOR INNOVATIVE THERAPIES AND DIAGNOSTICS

11. CELL ISOLATION MARKET, BY END USER

  • 11.1. INTRODUCTION
  • 11.2. BIOTECHNOLOGY & BIOPHARMACEUTICAL COMPANIES
    • 11.2.1. FAVORABLE INVESTMENTS HAVE BOOSTED OVERALL PACE OF RESEARCH
  • 11.3. RESEARCH LABORATORIES & INSTITUTES
    • 11.3.1. RISING FUNDING FOR CELL-BASED RESEARCH TO DRIVE MARKET GROWTH
  • 11.4. HOSPITALS & DIAGNOSTIC LABORATORIES
    • 11.4.1. INCREASING NUMBER OF HOSPITALS IN EMERGING COUNTRIES WILL CONTRIBUTE TO MARKET GROWTH
  • 11.5. OTHER END USERS

12. CELL ISOLATION MARKET, BY REGION

  • 12.1. INTRODUCTION
  • 12.2. NORTH AMERICA
    • 12.2.1. US
      • 12.2.1.1. US to witness the highest growth in the North American cell isolation market due to the increasing government funding on cell-based research
    • 12.2.2. CANADA
      • 12.2.2.1. Increasing funding for research in regenerative medicine to support market growth in Canada
  • 12.3. EUROPE
    • 12.3.1. GERMANY
      • 12.3.1.1. Germany to be fastest-growing market for cell isolation in Europe
    • 12.3.2. FRANCE
      • 12.3.2.1. Increasing prevalence of various chronic and infectious diseases to drive market growth
    • 12.3.3. UK
      • 12.3.3.1. Government investments in stem cell research to drive the market for cell isolation in the UK
    • 12.3.4. ITALY
      • 12.3.4.1. Increasing number of cell biology seminars and conferences to fuel the adoption of cell isolation products
    • 12.3.5. SPAIN
      • 12.3.5.1. Increasing funding from private and public organizations to aid market growth
    • 12.3.6. REST OF EUROPE (ROE)
  • 12.4. ASIA PACIFIC
    • 12.4.1. JAPAN
      • 12.4.1.1. Increasing geriatric population and substantial rise in the prevalence of chronic diseases will drive the market
    • 12.4.2. CHINA
      • 12.4.2.1. Cell therapy-based research is growing in China
    • 12.4.3. INDIA
      • 12.4.3.1. Rising incidence of chronic and infectious disease to drive demand for cell isolation products
    • 12.4.4. REST OF ASIA PACIFIC
  • 12.5. ROW
    • 12.5.1. LATIN AMERICA
      • 12.5.1.1. Rising incidence of chronic and infectious diseases will boost the market during the forecast period
    • 12.5.2. MIDDLE EAST AND AFRICA
      • 12.5.2.1. Increasing availability of funds will support the market in the MEA

13. COMPETITIVE LANDSCAPE

  • 13.1. OVERVIEW
  • 13.2. MARKET RANKING ANALYSIS, 2017
  • 13.3. KEY STRATEGIES
    • 13.3.1. PRODUCT LAUNCHES, 2015-2018
    • 13.3.2. EXPANSIONS, 2015-2018
    • 13.3.3. PARTNERSHIPS, 2015-2018
    • 13.3.4. ACQUISITIONS, 2015-2018
  • 13.4. COMPETITIVE LEADERSHIP MAPPING (2017)
    • 13.4.1. VANGUARDS
    • 13.4.2. INNOVATORS
    • 13.4.3. DYNAMIC PLAYERS
    • 13.4.4. EMERGING PLAYERS
  • 13.5. COMPETITIVE LEADERSHIP MAPPING FOR START-UPS (2017)
    • 13.5.1. PROGRESSIVE COMPANIES
    • 13.5.2. STARTING BLOCKS
    • 13.5.3. RESPONSIVE COMPANIES
    • 13.5.4. DYNAMIC COMPANIES

14. COMPANY PROFILES (Business Overview, Products Offered, Recent Developments, MnM View)*

  • 14.1. THERMO FISHER SCIENTIFIC, INC.
  • 14.2. BECTON, DICKINSON AND COMPANY
  • 14.3. BECKMAN COULTER INC. (SUBSIDIARY OF DANAHER CORPORATION)
  • 14.4. MERCK KGAA
  • 14.5. TERUMO BCT (SUBSIDIARY OF TERUMO CORPORATION)
  • 14.6. GE HEALTHCARE
  • 14.7. BIO-RAD LABORATORIES, INC.
  • 14.8. MILTENYI BIOTEC
  • 14.9. PLURISELECT LIFE SCIENCE UG (HAFTUNGSBESCHRANKT) & CO. KG
  • 14.10. STEMCELL TECHNOLOGIES, INC.

*Business Overview, Products Offered, Recent Developments, MnM View might not be captured in case of unlisted companies.

15. APPENDIX

  • 15.1. INSIGHTS OF INDUSTRY EXPERTS
  • 15.2. DISCUSSION GUIDE
  • 15.3. KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 15.4. AVAILABLE CUSTOMIZATIONS
  • 15.5. RELATED REPORTS
  • 15.1. AUTHOR DETAILS

LIST OF TABLES

  • TABLE 1: NIH FUNDING FOR CELL-BASED RESEARCH, 2014 VS. 2017 (USD MILLION)
  • TABLE 2: IMPORTANT STATISTICS ON INFECTIOUS DISEASES
  • TABLE 3: GROWTH IN THE NUMBER OF PERSONALIZED MEDICATIONS, 2008-2016
  • TABLE 4: CELL ISOLATION MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 5: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 6: CELL ISOLATION CONSUMABLES MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 7: CELL ISOLATION CONSUMABLES MARKET FOR REAGENTS, KITS, MEDIA, AND SERA, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 8: CELL ISOLATION CONSUMABLES MARKET FOR BEADS, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 9: CELL ISOLATION CONSUMABLES MARKET FOR DISPOSABLES, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 10: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 11: CELL ISOLATION INSTRUMENTS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 12: CELL ISOLATION INSTRUMENTS MARKET FOR CENTRIFUGES, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 13: CELL ISOLATION INSTRUMENTS MARKET FOR FLOW CYTOMETERS, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 14: CELL ISOLATION INSTRUMENTS MARKET FOR MAGNETIC-ACTIVATED CELL SEPARATOR SYSTEMS, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 15: CELL ISOLATION INSTRUMENTS MARKET FOR FILTRATION SYSTEMS, BY REGION, 2017-2024(USD MILLION)
  • TABLE 16: CELL ISOLATION MARKET, BY CELL TYPE, 2017-2024 (USD MILLION)
  • TABLE 17: HUMAN CELL ISOLATION MARKET, BY CELL TYPE, 2017-2024 (USD MILLION)
  • TABLE 18: HUMAN CELL ISOLATION MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 19: HUMAN DIFFERENTIATED CELL ISOLATION MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 20: HUMAN STEM CELL ISOLATION MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 21: ANIMAL CELL ISOLATION MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 22: CELL ISOLATION MARKET, BY CELL SOURCE, 2017-2024 (USD MILLION)
  • TABLE 23: BONE MARROW CELL ISOLATION MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 24: ADIPOSE TISSUE CELL ISOLATION MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 25: CORD BLOOD/EMBRYONIC STEM CELL ISOLATION MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 26: CELL ISOLATION MARKET, BY TECHNIQUE, 2017-2024 (USD MILLION)
  • TABLE 27: CENTRIFUGATION-BASED CELL ISOLATION MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 28: SURFACE MARKER-BASED CELL ISOLATION MARKET , BY REGION, 2017-2024 (USD MILLION)
  • TABLE 29: FILTRATION-BASED CELL ISOLATION MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 30: CELL ISOLATION MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 31: CELL ISOLATION MARKET FOR BIOMOLECULE ISOLATION, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 32: CELL ISOLATION MARKET FOR CANCER RESEARCH, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 33: CELL ISOLATION MARKET FOR STEM CELL RESEARCH, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 34: CELL ISOLATION MARKET FOR TISSUE REGENERATION & REGENERATIVE MEDICINE, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 35: CELL ISOLATION MARKET FOR IN VITRO DIAGNOSTICS, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 36: CELL ISOLATION MARKET, BY END USER, 2017-2021 (USD MILLION)
  • TABLE 37: CELL ISOLATION MARKET FOR BIOTECHNOLOGY & BIOPHARMACEUTICAL COMPANIES, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 38: CELL ISOLATION MARKET FOR RESEARCH LABORATORIES & INSTITUTES, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 39: CELL ISOLATION MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 40: CELL ISOLATION MARKET FOR OTHER END USERS, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 41: CELL ISOLATION MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 42: NORTH AMERICA: CELL ISOLATION MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 43: NORTH AMERICA: CELL ISOLATION MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 44: NORTH AMERICA: CELL ISOLATION CONSUMABLES MARKET, BY TYPE , 2017-2024 (USD MILLION)
  • TABLE 45: NORTH AMERICA: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 46: NORTH AMERICA: CELL ISOLATION MARKET, BY CELL TYPE, 2017-2024 (USD MILLION)
  • TABLE 47: NORTH AMERICA: HUMAN CELL ISOLATION MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 48: NORTH AMERICA: CELL ISOLATION MARKET, BY CELL SOURCE, 2017-2024 (USD MILLION)
  • TABLE 49: NORTH AMERICA: CELL ISOLATION MARKET, BY TECHNIQUE, 2017-2024 (USD MILLION)
  • TABLE 50: NORTH AMERICA: CELL ISOLATION MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 51: NORTH AMERICA: CELL ISOLATION MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 52: US: CELL ISOLATION MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 53: US: CELL ISOLATION CONSUMABLES MARKET, BY TYPE , 2017-2024 (USD MILLION)
  • TABLE 54: US: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 55: US: CELL ISOLATION MARKET, BY CELL TYPE, 2017-2024 (USD MILLION)
  • TABLE 56: US: HUMAN CELL ISOLATION MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 57: US: CELL ISOLATION MARKET, BY CELL SOURCE, 2017-2024 (USD MILLION)
  • TABLE 58: US: CELL ISOLATION MARKET, BY TECHNIQUE, 2017-2024 (USD MILLION)
  • TABLE 59: US: CELL ISOLATION MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 60: US: CELL ISOLATION MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 61: CANADA: CELL ISOLATION MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 62: CANADA: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 63: CANADA: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 64: CANADA: CELL ISOLATION MARKET, BY CELL TYPE, 2017-2024 (USD MILLION)
  • TABLE 65: CANADA: HUMAN CELL ISOLATION MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 66: CANADA: CELL ISOLATION MARKET, BY CELL SOURCE, 2017-2024 (USD MILLION)
  • TABLE 67: CANADA: CELL ISOLATION MARKET, BY TECHNIQUE, 2017-2024 (USD MILLION)
  • TABLE 68: CANADA: CELL ISOLATION MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 69: CANADA: CELL ISOLATION MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 70: EUROPE: CELL ISOLATION MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 71: EUROPE: CELL ISOLATION MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 72: EUROPE: CELL ISOLATION CONSUMABLES MARKET, BY TYPE , 2017-2024 (USD MILLION)
  • TABLE 73: EUROPE: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 74: EUROPE: CELL ISOLATION MARKET, BY CELL TYPE, 2017-2024 (USD MILLION)
  • TABLE 75: EUROPE: HUMAN CELL ISOLATION MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 76: EUROPE: CELL ISOLATION MARKET, BY CELL SOURCE, 2017-2024 (USD MILLION)
  • TABLE 77: EUROPE: CELL ISOLATION MARKET, BY TECHNIQUE, 2017-2024 (USD MILLION)
  • TABLE 78: EUROPE: CELL ISOLATION MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 79: EUROPE: CELL ISOLATION MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 80: GERMANY: CELL ISOLATION MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 81: GERMANY: CELL ISOLATION CONSUMABLES MARKET, BY TYPE , 2017-2024 (USD MILLION)
  • TABLE 82: GERMANY: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 83: GERMANY: CELL ISOLATION MARKET, BY CELL TYPE, 2017-2024 (USD MILLION)
  • TABLE 84: GERMANY: HUMAN CELL ISOLATION MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 85: GERMANY: CELL ISOLATION MARKET, BY CELL SOURCE, 2017-2024 (USD MILLION)
  • TABLE 86: GERMANY: CELL ISOLATION MARKET, BY TECHNIQUE, 2017-2024 (USD MILLION)
  • TABLE 87: GERMANY: CELL ISOLATION MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 88: GERMANY: CELL ISOLATION MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 89: FRANCE: CELL ISOLATION MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 90: FRANCE: CELL ISOLATION CONSUMABLES MARKET, BY TYPE , 2017-2024 (USD MILLION)
  • TABLE 91: FRANCE: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 92: FRANCE: CELL ISOLATION MARKET, BY CELL TYPE, 2017-2024 (USD MILLION)
  • TABLE 93: FRANCE: HUMAN CELL ISOLATION MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 94: FRANCE: CELL ISOLATION MARKET, BY CELL SOURCE, 2017-2024 (USD MILLION)
  • TABLE 95: FRANCE: CELL ISOLATION MARKET, BY TECHNIQUE, 2017-2024 (USD MILLION)
  • TABLE 96: FRANCE: CELL ISOLATION MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 97: FRANCE: CELL ISOLATION MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 98: UK: CELL ISOLATION MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 99: UK: CELL ISOLATION CONSUMABLES MARKET, BY TYPE , 2017-2024 (USD MILLION)
  • TABLE 100: UK: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 101: UK: CELL ISOLATION MARKET, BY CELL TYPE, 2017-2024 (USD MILLION)
  • TABLE 102: UK: HUMAN CELL ISOLATION MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 103: UK: CELL ISOLATION MARKET, BY CELL SOURCE, 2017-2024 (USD MILLION)
  • TABLE 104: UK: CELL ISOLATION MARKET, BY TECHNIQUE, 2017-2024 (USD MILLION)
  • TABLE 105: UK: CELL ISOLATION MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 106: UK: CELL ISOLATION MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 107: ITALY: CELL ISOLATION MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 108: ITALY: CELL ISOLATION CONSUMABLES MARKET, BY TYPE , 2017-2024 (USD MILLION)
  • TABLE 109: ITALY: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 110: ITALY: CELL ISOLATION MARKET, BY CELL TYPE, 2017-2024 (USD MILLION)
  • TABLE 111: ITALY: HUMAN CELL ISOLATION MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 112: ITALY: CELL ISOLATION MARKET, BY CELL SOURCE, 2017-2024 (USD MILLION)
  • TABLE 113: ITALY: CELL ISOLATION MARKET, BY TECHNIQUE, 2017-2024 (USD MILLION)
  • TABLE 114: ITALY: CELL ISOLATION MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 115: ITALY: CELL ISOLATION MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 116: SPAIN: CELL ISOLATION MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 117: SPAIN: CELL ISOLATION CONSUMABLES MARKET, BY TYPE , 2017-2024 (USD MILLION)
  • TABLE 118: SPAIN: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 119: SPAIN: CELL ISOLATION MARKET, BY CELL TYPE, 2017-2024 (USD MILLION)
  • TABLE 120: SPAIN: HUMAN CELL ISOLATION MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 121: SPAIN: CELL ISOLATION MARKET, BY CELL SOURCE, 2017-2024 (USD MILLION)
  • TABLE 122: SPAIN: CELL ISOLATION MARKET, BY TECHNIQUE, 2017-2024 (USD MILLION)
  • TABLE 123: SPAIN: CELL ISOLATION MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 124: SPAIN: CELL ISOLATION MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 125: ROE: CELL ISOLATION MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 126: ROE: CELL ISOLATION CONSUMABLES MARKET, BY TYPE , 2017-2024 (USD MILLION)
  • TABLE 127: ROE: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 128: ROE: CELL ISOLATION MARKET, BY CELL TYPE, 2017-2024 (USD MILLION)
  • TABLE 129: ROE: HUMAN CELL ISOLATION MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 130: ROE: CELL ISOLATION MARKET, BY CELL SOURCE, 2017-2024 (USD MILLION)
  • TABLE 131: ROE: CELL ISOLATION MARKET, BY TECHNIQUE, 2017-2024 (USD MILLION)
  • TABLE 132: ROE: CELL ISOLATION MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 133: ROE: CELL ISOLATION MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 134: ASIA PACIFIC: CELL ISOLATION MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 135: ASIA PACIFIC: CELL ISOLATION MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 136: ASIA PACIFIC: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 137: ASIA PACIFIC: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 138: ASIA PACIFIC: CELL ISOLATION MARKET, BY CELL TYPE, 2017-2024 (USD MILLION)
  • TABLE 139: ASIA PACIFIC: HUMAN CELL ISOLATION MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 140: ASIA PACIFIC: CELL ISOLATION MARKET, BY CELL SOURCE, 2017-2024 (USD MILLION)
  • TABLE 141: ASIA PACIFIC: CELL ISOLATION MARKET, BY TECHNIQUE, 2017-2024 (USD MILLION)
  • TABLE 142: ASIA PACIFIC: CELL ISOLATION MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 143: ASIA PACIFIC: CELL ISOLATION MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 144: JAPAN: CELL ISOLATION MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 145: JAPAN: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 146: JAPAN: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 147: JAPAN: CELL ISOLATION MARKET, BY CELL TYPE, 2017-2024 (USD MILLION)
  • TABLE 148: JAPAN: HUMAN CELL ISOLATION MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 149: JAPAN: CELL ISOLATION MARKET, BY CELL SOURCE, 2017-2024 (USD MILLION)
  • TABLE 150: JAPAN: CELL ISOLATION MARKET, BY TECHNIQUE, 2017-2024 (USD MILLION)
  • TABLE 151: JAPAN: CELL ISOLATION MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 152: JAPAN: CELL ISOLATION MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 153: CHINA: CELL ISOLATION MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 154: CHINA: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 155: CHINA: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 156: CHINA: CELL ISOLATION MARKET, BY CELL TYPE, 2017-2024 (USD MILLION)
  • TABLE 157: CHINA: HUMAN CELL ISOLATION MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 158: CHINA: CELL ISOLATION MARKET, BY CELL SOURCE, 2017-2024 (USD MILLION)
  • TABLE 159: CHINA: CELL ISOLATION MARKET, BY TECHNIQUE, 2017-2024 (USD MILLION)
  • TABLE 160: CHINA: CELL ISOLATION MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 161: CHINA: CELL ISOLATION MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 162: INDIA: CELL ISOLATION MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 163: INDIA: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 164: INDIA: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 165: INDIA: CELL ISOLATION MARKET, BY CELL TYPE, 2017-2024 (USD MILLION)
  • TABLE 166: INDIA: HUMAN CELL ISOLATION MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 167: INDIA: CELL ISOLATION MARKET, BY CELL SOURCE, 2017-2024 (USD MILLION)
  • TABLE 168: INDIA: CELL ISOLATION MARKET, BY TECHNIQUE, 2017-2024 (USD MILLION)
  • TABLE 169: INDIA: CELL ISOLATION MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 170: INDIA: CELL ISOLATION MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 171: ROAPAC: CELL ISOLATION MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 172: ROAPAC: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 173: ROAPAC: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 174: ROAPAC: CELL ISOLATION MARKET, BY CELL TYPE, 2017-2024 (USD MILLION)
  • TABLE 175: ROAPAC: HUMAN CELL ISOLATION MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 176: ROAPAC: CELL ISOLATION MARKET, BY CELL SOURCE, 2017-2024 (USD MILLION)
  • TABLE 177: ROAPAC: CELL ISOLATION MARKET, BY TECHNIQUE, 2017-2024 (USD MILLION)
  • TABLE 178: ROAPAC: CELL ISOLATION MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 179: ROAPAC: CELL ISOLATION MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 180: ROW: CELL ISOLATION MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 181: ROW: CELL ISOLATION MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 182: ROW: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 183: ROW: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 184: ROW: CELL ISOLATION MARKET, BY CELL TYPE, 2017-2024 (USD MILLION)
  • TABLE 185: ROW: HUMAN CELL ISOLATION MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 186: ROW: CELL ISOLATION MARKET, BY CELL SOURCE, 2017-2024 (USD MILLION)
  • TABLE 187: ROW: CELL ISOLATION MARKET, BY TECHNIQUE, 2017-2024 (USD MILLION)
  • TABLE 188: ROW: CELL ISOLATION MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 189: ROW: CELL ISOLATION MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 190: LATIN AMERICA: CELL ISOLATION MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 191: LATIN AMERICA: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 192: LATIN AMERICA: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 193: LATIN AMERICA: CELL ISOLATION MARKET, BY CELL TYPE, 2017-2024 (USD MILLION)
  • TABLE 194: LATIN AMERICA: HUMAN CELL ISOLATION MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 195: LATIN AMERICA: CELL ISOLATION MARKET, BY CELL SOURCE, 2017-2024 (USD MILLION)
  • TABLE 196: LATIN AMERICA: CELL ISOLATION MARKET, BY TECHNIQUE, 2017-2024 (USD MILLION)
  • TABLE 197: LATIN AMERICA: CELL ISOLATION MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 198: LATIN AMERICA: CELL ISOLATION MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 199: MIDDLE EAST AND AFRICA: CELL ISOLATION MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 200: MIDDLE EAST AND AFRICA: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 201: MIDDLE EAST AND AFRICA: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 202: MIDDLE EAST AND AFRICA: CELL ISOLATION MARKET, BY CELL TYPE, 2017-2024 (USD MILLION)
  • TABLE 203: MIDDLE EAST AND AFRICA: HUMAN CELL ISOLATION MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 204: MIDDLE EAST AND AFRICA: CELL ISOLATION MARKET, BY CELL SOURCE, 2017-2024 (USD MILLION)
  • TABLE 205: MIDDLE EAST AND AFRICA: CELL ISOLATION MARKET, BY TECHNIQUE, 2017-2024 (USD MILLION)
  • TABLE 206: MIDDLE EAST AND AFRICA: CELL ISOLATION MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 207: MIDDLE EAST AND AFRICA: CELL ISOLATION MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 208: TOP FIVE COMPANIES IN THE CELL ISOLATION MARKET, 2017

LIST OF FIGURES

  • FIGURE 1: GLOBAL CELL ISOLATION MARKET
  • FIGURE 2: GLOBAL CELL ISOLATION MARKET COUNTRY COVERAGE
  • FIGURE 3: GLOBAL CELL ISOLATION MARKET YEARS CONSIDERED FOR THE STUDY
  • FIGURE 4: RESEARCH DESIGN
  • FIGURE 5: BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 6: CELL ISOLATION MARKET: BOTTOM-UP APPROACH
  • FIGURE 7: CELL ISOLATION MARKET: TOP-DOWN APPROACH
  • FIGURE 8: DATA TRIANGULATION METHODOLOGY
  • FIGURE 9: CELL ISOLATION MARKET, BY PRODUCT, 2019 VS. 2024 (USD BILLION)
  • FIGURE 10: CELL ISOLATION MARKET, BY CELL TYPE, 2019 VS. 2024 (USD BILLION)
  • FIGURE 11: CELL ISOLATION MARKET, BY CELL SOURCE, 2019 VS. 2024 (USD BILLION)
  • FIGURE 12: CELL ISOLATION MARKET, BY TECHNIQUE, 2019 VS. 2024 (USD BILLION)
  • FIGURE 13: CELL ISOLATION MARKET, BY APPLICATION, 2019 VS. 2024 (USD BILLION)
  • FIGURE 14: CELL ISOLATION MARKET, BY END USER, 2019 VS. 2024 (USD BILLION)
  • FIGURE 15: CELL ISOLATION MARKET, BY REGION, 2019 VS. 2024 (USD BILLION)
  • FIGURE 16: INCREASING FUNDING FOR CELL-BASED RESEARCH TO DRIVE MARKET GROWTH DURING THE FORECAST PERIOD
  • FIGURE 17: CONSUMABLES DOMINATED THE NORTH AMERICAN CELL ISOLATION MARKET IN 2018
  • FIGURE 18: COUNTRIES IN ASIA PACIFIC TO REGISTER A HIGHER GROWTH RATE DURING THE FORECAST PERIOD
  • FIGURE 19: CELL ISOLATION MARKET: DRIVERS, RESTRAINTS, & OPPORTUNITIES
  • FIGURE 20: INCIDENCE OF CANCER, BY REGION, 2012-2035 (MILLION)
  • FIGURE 21: CONSUMABLES TO DOMINATE THE CELL ISOLATION PRODUCTS MARKET DURING THE FORECAST PERIOD
  • FIGURE 22: HUMAN CELLS SEGMENT TO DOMINATE THE MARKET DURING THE FORECAST PERIOD
  • FIGURE 23: BONE MARROW SEGMENT TO DOMINATE THE CELL ISOLATION MARKET DURING FORECAST PERIOD
  • FIGURE 24: CENTRIFUGATION-BASED CELL ISOLATION TO DOMINATE THE MARKET IN 2019
  • FIGURE 25: BIOMOLECULE ISOLATION SEGMENT TO DOMINATE THE CELL ISOLATION MARKET DURING THE FORECAST PERIOD
  • FIGURE 26: BIOTECHNOLOGY & BIOPHARMACEUTICAL COMPANIES TO DOMINATE THE END-USER MARKET FOR CELL ISOLATION
  • FIGURE 27: NORTH AMERICA WILL CONTINUE TO DOMINATE THE CELL ISOLATION MARKET IN 2024
  • FIGURE 28: NORTH AMERICA: CELL ISOLATION MARKET SNAPSHOT
  • FIGURE 29: INCIDENCE OF CANCER IN FRANCE
  • FIGURE 30: INCIDENCE OF CANCER IN SPAIN
  • FIGURE 31: ASIA PACIFIC: CELL ISOLATION MARKET SNAPSHOT
  • FIGURE 32: PROJECTED RISE IN CANCER INCIDENCE IN JAPAN
  • FIGURE 33: INCIDENCE OF CANCER IN CHINA
  • FIGURE 34: INCIDENCE OF CANCER IN INDIA
  • FIGURE 35: NUMBER OF NEW HIV INFECTIONS DIAGNOSED IN LATIN AMERICAN COUNTRIES
  • FIGURE 36: KEY DEVELOPMENTS IN THE CELL ISOLATION MARKET FROM 2015 TO 2018
  • FIGURE 37: MNM DIVE-VENDOR COMPARISON MATRIX: CELL ISOLATION MARKET
  • FIGURE 38: MNM DIVE-VENDOR COMPARISON MATRIX FOR START-UPS: CELL ISOLATION MARKET
  • FIGURE 39: THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT (2017)
  • FIGURE 40: BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2018)
  • FIGURE 41: DANAHER CORPORATION: COMPANY SNAPSHOT (2017)
  • FIGURE 42: MERCK KGAA: COMPANY SNAPSHOT (2017)
  • FIGURE 43: TERUMO CORPORATION: COMPANY SNAPSHOT (2017)
  • FIGURE 44: GE HEALTHCARE: COMPANY SNAPSHOT (2017)
  • FIGURE 45: BIO-RAD LABORATORIES: COMPANY SNAPSHOT (2017)